Writing as a son of an 83-year-old father with moderate vascular dementia and metastatic prostate cancer (mPCa). Both this conditions are worsening.
Firstly, thank you for all the feedback on my previous posts—this forum has been incredibly helpful for both education and support. healthunlocked.com/advanced...
We are at the stage where his PSA has doubled in two months to 262. He only received one three-month injection of ADT before stopping due to significant side effects, including increased confusion, a delirium episode that led to hospitalization, and extreme fatigue.
He was also taking daily bicalutamide, but that has now been discontinued since his PSA continued to rise. His most recent CT scan shows bone metastases in his leg, abdomen, and pelvis. Currently, he is experiencing pain in his femur.
His radiation oncologist has suggested palliative radiation as an option when pain management with oral medications is no longer sufficient.
My stepmother and my dad (as best as I can tell) want to focus on quality of life rather than longevity, especially given how poorly he tolerated ADT. His dementia has progressed significantly over the past nine months—it’s no longer just forgetfulness, but more irrational thoughts and conversations. Fortunately, he still recognizes family and remains at home.
I’ve appreciated the suggestions of one-month ADT, oral ADT, Abiraterone, and Degarelix, and I plan to ask about these at our meeting with the radiation oncologist tomorrow. However, I suspect the potential side effects may make my stepmother hesitant to pursue these options. Additionally, some of the treatments available in the US (radio pharmaceuticals, relugolix-Orgovyx ) are not available here in New Zealand.
I also plan to ask about bone-targeted therapies, such as bisphosphonates or denosumab.
One thing I don’t fully understand is the trajectory of metastatic prostate cancer when it begins progressing rapidly. This will be an important topic for discussion—what to expect as the disease advances and whether there is any palliative benefit to additional treatments. The priority now is for him to have the best QOL in the near term and treat the effects of the PCa progression.
At this stage, I’m just trying to process everything and support my dad the best I can. If anyone has been through a similar situation—especially balancing prostate cancer treatment decisions with dementia—I’d really appreciate hearing your experiences. Any insights on what to expect or how to approach these conversations would be very helpful.